- Home
- PRQR vs NCV Comparison
PRQR vs NCV Comparison
Compare PRQR & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- NCV
- Stock Information
- Founded
- PRQR 2012
- NCV 2003
- Country
- PRQR Netherlands
- NCV United States
- Employees
- PRQR N/A
- NCV N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- NCV Finance Companies
- Sector
- PRQR Health Care
- NCV Finance
- Exchange
- PRQR Nasdaq
- NCV Nasdaq
- Market Cap
- PRQR 179.1M
- NCV 317.4M
- IPO Year
- PRQR 2014
- NCV N/A
- Fundamental
- Price
- PRQR $2.35
- NCV $14.16
- Analyst Decision
- PRQR Strong Buy
- NCV
- Analyst Count
- PRQR 8
- NCV 0
- Target Price
- PRQR $8.88
- NCV N/A
- AVG Volume (30 Days)
- PRQR 357.1K
- NCV 405.1K
- Earning Date
- PRQR 08-07-2025
- NCV 01-01-0001
- Dividend Yield
- PRQR N/A
- NCV 12.48%
- EPS Growth
- PRQR N/A
- NCV N/A
- EPS
- PRQR N/A
- NCV N/A
- Revenue
- PRQR $21,212,711.00
- NCV N/A
- Revenue This Year
- PRQR N/A
- NCV N/A
- Revenue Next Year
- PRQR N/A
- NCV N/A
- P/E Ratio
- PRQR N/A
- NCV N/A
- Revenue Growth
- PRQR 85.91
- NCV N/A
- 52 Week Low
- PRQR $1.07
- NCV $2.84
- 52 Week High
- PRQR $4.62
- NCV $3.59
- Technical
- Relative Strength Index (RSI)
- PRQR 66.90
- NCV 62.28
- Support Level
- PRQR $2.10
- NCV $14.06
- Resistance Level
- PRQR $2.18
- NCV $14.35
- Average True Range (ATR)
- PRQR 0.13
- NCV 0.14
- MACD
- PRQR 0.01
- NCV 0.01
- Stochastic Oscillator
- PRQR 56.92
- NCV 76.22
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.